Stock Roaring Upward Mid-Session: Gemphire Therapeutics Inc. (NASDAQ:GEMP)

Shares of Gemphire Therapeutics Inc. (NASDAQ:GEMP) are scrambling higher in today’s trading session. At the time of writing, the stock had reached $9.73. This represents a change from the opening price of 5.72%.

The year-to-date performance of the stock is 14.35%. The monthly stock performance comes in at -5.83%. For the quarter, shares are performing at 5.10%. Weekly performance analysis shows the equity at -7.86%.Covering Sell-Side analysts have offered recommendations and price target estimates on Gemphire Therapeutics Inc. (NASDAQ:GEMP). According to First Call, the current consensus target price on shares is sitting at $23.67. Analysts have also given a consensus recommendation on the stock of 1.70. This number lands on a scale from 1 to 5. A rating of 4 or 5 would indicate a Sell. A rating of 1 or 2 would represent a Buy, and a 3 rating would signify a Hold on the stock.

Shares of Gemphire Therapeutics Inc. are presently 35.08% off the 52 week low. On the flip side, the stock is -54.95% away from the 52 week high. Current price levels see the company 2.05% off the 20-day simple moving average. The average volume stands around 19985. Trading volume may be a very important factor for any investor. 

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples.

They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.

Leave a Comment